Keywords
Last Name
Institution

Eran Chemerinski

TitleASSISTANT PROFESSOR
InstitutionMount Sinai
DepartmentPsychiatry
Address

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Hamilton AB, Cohen AN, Glover DL, Whelan F, Chemerinski E, McNagny KP, Mullins D, Reist C, Schubert M, Young AS. Implementation of evidence-based employment services in specialty mental health. Health Serv Res. 2013 Dec; 48(6 Pt 2):2224-44.
      View in: PubMed
    2. Triebwasser J, Chemerinski E, Roussos P, Siever LJ. Schizoid personality disorder. J Pers Disord. 2012 Dec; 26(6):919-26.
      View in: PubMed
    3. Chemerinski E, Byne W, Kolaitis JC, Glanton CF, Canfield EL, Newmark RE, Haznedar MM, Novakovic V, Chu KW, Siever LJ, Hazlett EA. Larger putamen size in antipsychotic-naïve individuals with schizotypal personality disorder. Schizophr Res. 2013 Jan; 143(1):158-64.
      View in: PubMed
    4. Chemerinski E, Triebwasser J, Roussos P, Siever LJ. Schizotypal personality disorder. J Pers Disord. 2013 Oct; 27(5):652-79.
      View in: PubMed
    5. Triebwasser J, Chemerinski E, Roussos P, Siever LJ. Paranoid personality disorder. J Pers Disord. 2013 Dec; 27(6):795-805.
      View in: PubMed
    6. Chemerinski E, Bowie C, Anderson H, Harvey PD. Depression in schizophrenia: methodological artifact or distinct feature of the illness? J Neuropsychiatry Clin Neurosci. 2008; 20(4):431-40.
      View in: PubMed
    7. Chemerinski E, Levine SR. Neuropsychiatric disorders following vascular brain injury. Mt Sinai J Med. 2006 Nov; 73(7):1006-14.
      View in: PubMed
    8. Chemerinski E, Reichenberg A, Kirkpatrick B, Bowie CR, Harvey PD. Three dimensions of clinical symptoms in elderly patients with schizophrenia: prediction of six-year cognitive and functional status. Schizophr Res. 2006 Jul; 85(1-3):12-9.
      View in: PubMed
    9. Crespo-Facorro B, Nopoulos PC, Chemerinski E, Kim JJ, Andreasen NC, Magnotta V. Temporal pole morphology and psychopathology in males with schizophrenia. Psychiatry Res. 2004 Dec 15; 132(2):107-15.
      View in: PubMed
    10. Jorge RE, Robinson RG, Tateno A, Narushima K, Acion L, Moser D, Arndt S, Chemerinski E. Repetitive transcranial magnetic stimulation as treatment of poststroke depression: a preliminary study. Biol Psychiatry. 2004 Feb 15; 55(4):398-405.
      View in: PubMed
    11. Crespo-Facorro B, Kim JJ, Chemerinski E, Magnotta V, Andreasen NC, Nopoulos P. Morphometry of the superior temporal plane in schizophrenia: relationship to clinical correlates. J Neuropsychiatry Clin Neurosci. 2004; 16(3):284-94.
      View in: PubMed
    12. Chemerinski E, Ho BC, Flaum M, Arndt S, Fleming F, Andreasen NC. Insomnia as a predictor for symptom worsening following antipsychotic withdrawal in schizophrenia. Compr Psychiatry. 2002 Sep-Oct; 43(5):393-6.
      View in: PubMed
    13. Chemerinski E, Nopoulos PC, Crespo-Facorro B, Andreasen NC, Magnotta V. Morphology of the ventral frontal cortex in schizophrenia: relationship with social dysfunction. Biol Psychiatry. 2002 Jul 1; 52(1):1-8.
      View in: PubMed
    14. Starkstein SE, Petracca G, Chemerinski E, Merello M. Prevalence and correlates of parkinsonism in patients with primary depression. Neurology. 2001 Aug 14; 57(3):553-5.
      View in: PubMed
    15. Chemerinski E, Robinson RG, Arndt S, Kosier JT. The effect of remission of poststroke depression on activities of daily living in a double-blind randomized treatment study. J Nerv Ment Dis. 2001 Jul; 189(7):421-5.
      View in: PubMed
    16. Starkstein SE, Petracca G, Chemerinski E, Kremer J. Syndromic validity of apathy in Alzheimer's disease. Am J Psychiatry. 2001 Jun; 158(6):872-7.
      View in: PubMed
    17. Petracca GM, Chemerinski E, Starkstein SE. A double-blind, placebo-controlled study of fluoxetine in depressed patients with Alzheimer's disease. Int Psychogeriatr. 2001 Jun; 13(2):233-40.
      View in: PubMed
    18. Chemerinski E, Robinson RG, Kosier JT. Improved recovery in activities of daily living associated with remission of poststroke depression. Stroke. 2001 Jan; 32(1):113-7.
      View in: PubMed
    19. Chemerinski E, Petracca G, Sabe L, Kremer J, Starkstein SE. The specificity of depressive symptoms in patients with Alzheimer's disease. Am J Psychiatry. 2001 Jan; 158(1):68-72.
      View in: PubMed
    20. Torralva T, Dorrego F, Sabe L, Chemerinski E, Starkstein SE. Impairments of social cognition and decision making in Alzheimer's disease. Int Psychogeriatr. 2000 Sep; 12(3):359-68.
      View in: PubMed
    21. Chemerinski E, Robinson RG. The neuropsychiatry of stroke. Psychosomatics. 2000 Jan-Feb; 41(1):5-14.
      View in: PubMed
    22. Paradiso S, Chemerinski E, Yazici KM, Tartaro A, Robinson RG. Frontal lobe syndrome reassessed: comparison of patients with lateral or medial frontal brain damage. J Neurol Neurosurg Psychiatry. 1999 Nov; 67(5):664-7.
      View in: PubMed
    23. Robinson RG, Chemerinski E, Jorge R. Pathophysiology of secondary depressions in the elderly. J Geriatr Psychiatry Neurol. 1999; 12(3):128-36.
      View in: PubMed
    24. Starkstein SE, Petracca G, Chemerinski E, Tesón A, Sabe L, Merello M, Leiguarda R. Depression in classic versus akinetic-rigid Parkinson's disease. Mov Disord. 1998 Jan; 13(1):29-33.
      View in: PubMed
    25. Chemerinski E, Petracca G, Tesón A, Sabe L, Leiguarda R, Starkstein SE. Prevalence and correlates of aggressive behavior in Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 1998; 10(4):421-5.
      View in: PubMed
    26. Chemerinski E, Petracca G, Manes F, Leiguarda R, Starkstein SE. Prevalence and correlates of anxiety in Alzheimer's disease. Depress Anxiety. 1998; 7(4):166-70.
      View in: PubMed
    27. Starkstein SE, Sabe L, Vázquez S, Di Lorenzo G, Martínez A, Petracca G, Tesón A, Chemerinski E, Leiguarda R. Neuropsychological, psychiatric, and cerebral perfusion correlates of leukoaraiosis in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1997 Jul; 63(1):66-73.
      View in: PubMed
    28. Starkstein SE, Chemerinski E, Sabe L, Kuzis G, Petracca G, Tesón A, Leiguarda R. Prospective longitudinal study of depression and anosognosia in Alzheimer's disease. Br J Psychiatry. 1997 Jul; 171:47-52.
      View in: PubMed
    29. Starkstein SE, Sabe L, Chemerinski E, Jason L, Leiguarda R. Two domains of anosognosia in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1996 Nov; 61(5):485-90.
      View in: PubMed
    30. Starkstein SE, Sabe L, Petracca G, Chemerinski E, Kuzis G, Merello M, Leiguarda R. Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia. J Neurol Neurosurg Psychiatry. 1996 Oct; 61(4):381-7.
      View in: PubMed
    31. Starkstein SE, Petracca G, Tesón A, Chemerinski E, Merello M, Migliorelli R, Leiguarda R. Catatonia in depression: prevalence, clinical correlates, and validation of a scale. J Neurol Neurosurg Psychiatry. 1996 Mar; 60(3):326-32.
      View in: PubMed
    32. Starkstein SE, Sabe L, Vazquez S, Teson A, Petracca G, Chemerinski E, Di Lorenzo G, Leiguarda R. Neuropsychological, psychiatric, and cerebral blood flow findings in vascular dementia and Alzheimer's disease. Stroke. 1996 Mar; 27(3):408-14.
      View in: PubMed
    33. Petracca G, Tesón A, Chemerinski E, Leiguarda R, Starkstein SE. A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 1996; 8(3):270-5.
      View in: PubMed
    34. Starkstein SE, Migliorelli R, Manes F, Tesón A, Petracca G, Chemerinski E, Sabe L, Leiguarda R. The prevalence and clinical correlates of apathy and irritability in Alzheimer's disease. Eur J Neurol. 1995 Dec; 2(6):540-6.
      View in: PubMed
    35. Giarcovich-Martínez S, Fernandez M, Chemerinski E, Enero MA. Central serotonergic activity after neurogenic hypertension. Eur J Pharmacol. 1983 Jan 21; 86(3-4):337-45.
      View in: PubMed
    36. Ramírez AJ, Chemerinski E, Enero MA. Central serotonergic participation on blood pressure regulation. Gen Pharmacol. 1982; 13(5):427-32.
      View in: PubMed
    37. Chemerinski E, Ramírez AJ, Enero MA. Sinoaortic denervation-induced changes in central serotonergic neurons. Eur J Pharmacol. 1980 Jun 13; 64(2-3):195-8.
      View in: PubMed
    38. Merlo AB, Fabian HE, Chemerinski E, Billiet M. Effect of d-amphetamine, ethanol and genever on learning in the rat. Pharmacol Biochem Behav. 1976 Mar; 4(3):239-42.
      View in: PubMed
    39. Izquierdo JA, Merlo AB, Chemerinski E, Billiet M. Effects of ethanol and sherry on the performance of a conditioned response in the rat. Pharmacol Biochem Behav. 1974 May; 2(3):317-23.
      View in: PubMed
    40. Izquierdo JA, Fabian HE, Chemerinski E. Effects of d- and 1- propranolol on spontaneous motility and retention in male mice. Acta Physiol Lat Am. 1974; 24(6):669-70.
      View in: PubMed
    41. Fabian HE, Chemerinski E, Merlo AB, Izquierdo JA. Effect of propranolol on free fatty acids of mice plasma during a passive avoidance test. Psychopharmacologia. 1973 Jun 29; 30(4):369-74.
      View in: PubMed
    Chemerinski's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067